S.C Policlinica CCBR S.R.L
About S.C Policlinica CCBR S.R.L
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nordic Bioscience A/S
3
Pfizer
3
Arena Pharmaceuticals
2
Kowa Research Institute, Inc.
1
Clinical Trials at S.C Policlinica CCBR S.R.L
During the past decade, S.C Policlinica CCBR S.R.L conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
2007-05-01
2010-09-01
Completed
1,176
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
2007-03-01
2011-11-01
Completed
4,665
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
2008-06-01
2011-06-01
Terminated
1,030
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C Policlinica CCBR S.R.L"
#1 collaborator was "Novartis" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at S.C Policlinica CCBR S.R.L
According to Clinical.Site data, the most researched conditions in "S.C Policlinica CCBR S.R.L" are
"Cardiovascular Disease" (2 trials), "Osteoarthritis" (2 trials), "Ulcerative Colitis" (2 trials), "Crohn's Disease" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "S.C Policlinica CCBR S.R.L" in a lesser frequency.
Clinical Trials Intervention Types at S.C Policlinica CCBR S.R.L
Most popular intervention types in "S.C Policlinica CCBR S.R.L" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (3 trials), "SMC021 Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "K-877" (1 trials). Other intervention names were less common.
Clinical Trials Genders at S.C Policlinica CCBR S.R.L
The vast majority of trials in "S.C Policlinica CCBR S.R.L" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at S.C Policlinica CCBR S.R.L
Currently, there are NaN active trials in "S.C Policlinica CCBR S.R.L".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in S.C Policlinica CCBR S.R.L,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in S.C Policlinica CCBR S.R.L, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".